Information Library
Targeted communications
To learn more about a particular aspect of Quintiles’ pharma services, biotech development or drug commercialization services, select a topic at left. If you’ve already specified a choice, you may narrow your search by selecting additional categories in any order. For example, for information on oncology drug development, start by selecting oncology. Then you can narrow your search to Central Lab, News Releases and Europe.
- Sort by: Most Recent
- Title
-
QUINTILES AND ALLERGAN ANNOUNCE CO-PROMOTION AGREEMENT
September 25, 2009 – Quintiles Transnational Corp. and Allergan, Inc. today announced an agreement under which Quintiles will co-promote Allergan's SANCTURA XR®. -
Utility of Adiponectin as a Biomarker Predictive of Glycemic Efficacy
June 29, 2009
The project pooled blinded data from existing completed clinical trials contributed by Eli Lilly and Company, GlaxoSmithKline, Hoffmann-LaRoche, Inc, and Merck Research Laboratories into a single database hosted by Quintiles Transnational Corporation. -
Medicare Part D’s Effect On Prescribing Volume
June 25, 2009
Poster presented during the ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) titled “Medicare Part D’s Effect On Prescribing Volume: Average Monthly Utilization of Selected High Use Drugs In The Six Protected Classes, By Different Specialties.” -
Diabetes Proactive Proposal
June 24, 2009
New FDA Guidances On Anti-Diabetes Therapies Change the Landscape of Drug Development. How Quintiles Can Help You Navigate the Guidances and Successfully Develop Pipeline Drug Candidates. -
Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.
June 24, 2009
Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.” -
Innovex Medical Communications Experience
June 5, 2009
Innovex Medical Communications (IMC) has over 20 years of experience delivering global medical communication programmes for the top 20 global Pharma companies. -
Organizing Events, Advisory Boards and Meetings
June 5, 2009
In the past 5 years, IMC has delivered over 250 meetings to 13,500 delegates. -
IMC Multi-Country Expertise
June 5, 2009
Our educational materials have been used in over 30 countries and translated into 48 languages. -
Contact Details IMC
June 5, 2009
Names & contact details of IMC contact persons. -
Quintiles CRA School
April 10, 2009
Quintiles CRA SQL to nie tylko intensywny program przygotowujący do pracy w zawodzie Monitora Badań Klinicznych, ale przede wszystkim możliwość zdobycia wiedzy, która daje szansę nakreślenia zupełnie nowej ścieżki w karierze. Quintiles CRA SQL to szansa na rozwój i podjęcie nowego zawodowego wyzwania oraz poznanie obszaru badań klinicznych.